Lack of evidence to support the association of polymorphisms within the TNFSF4 gene and coronary heart disease in a Chinese Han population

Experimental and Therapeutic Medicine

Volumn 2, Issue 2, 2011, Pages 275-280

  Cheng, Guanghui ^a   Wang, Hui ^a   Chen, Minzhi ^a   Li, Li ^b   Gong, Yaoqin ^a   Liu, Qiji ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Association study; Coronary heart disease; Polymorphism; Tumor necrosis factor super family member 4

Indexed keywords

CHOLESTEROL; GLUCOSE; OX40 LIGAND; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHINESE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

EID: 79551628826     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2010.188     Document Type: Article

References (14)

1. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695, 2005.
2. Hansson GK, Libby P, Schonbeck U and Yan ZQ: Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 91: 281-291, 2002.
3. De Boer OJ, Becker AE and van der Wal AC: T lymphocytes in atherogenesis-functional aspects and antigenic repertoire. Cardiovasc Res 60: 78-86, 2003.
4. Walker LS, Gulbranson-Judge A, Flynn S, Brocker T and lane PJ: Co-stimulation and selection for T-cell help for germinal centres: the role of CD28 and OX40. Immunol Today 21: 333-337, 2000.
5. Weinberg AD: Ox40: targeted immunotherapy - implications for tempering autoimmunity and enhancing vaccines. Trends immunol 23: 102-109, 2002.
6. Ria M, Eriksson P, Boquist S, Ericsson CG, Hamsten A and Lagercrantz J: human genetic evidence that OX40 is implicated in myocardial infarction. Biochem Biophys Res Commun 339: 1001-1006, 2006.
7. Mashimo Y, Suzuki Y, Hatori K, Tabara Y, Miki T, Tokunaga K, Katsuya T, Ogihara T, Yamada M, Takahashi N, Makita Y, Nakayama T, Soma M, Hirawa N, Umemura S, Ohkubo T, Imai Y and Hata A: Association of TNFRSF4 gene polymorphisms with essential hypertension. J Hypertens 26: 902-913, 2008.
8. Wang X, Ria M, Kelmenson PM, Eriksson P, et al: Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat Genet 37: 365-372, 2005.
9. Malarstig A, Eriksson P, Rose L, Diehl KA, Hamsten A, Ridker PM and Zee RY: Genetic variants of tumor necrosis factor superfamily, member 4 (TNFSF4), and risk of incident atherothrombosis and venous thromboembolism. Clin Chem 54: 833-840, 2008.
10. Van Wanrooij EJ, van Puijvelde GH, de Vos P, Yagita H, van Berkel TJ and Kuiper J: Interruption of the TNFRSF4/ TNFSF4 (OX40/OX40l) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 27: 204-210, 2007.
11. Menashe I, Rosenberg PS and Chen BE: PGA: Power calculator for case-control genetic association analyses. BMC Genet 9: 36, 2008.
12. Hansson GK, Robertson AK and Soderberg-Naucler C: Inflammation and atherosclerosis. Annu Rev Pathol 1: 297-329, 2006.
13. Koch W, Hoppmann P, Mueller JC, Schomig A and Kastrati A: Lack of support for association between common variation in TNFSF4 and myocardial infarction in a German population. Nat Genet 40: 1386-1388, 2008.
14. Olofsson PS, Soderstrom LA, Jern C, Sirsjo A, Ria M, Sundler E, de Faire U, Wiklund PG, Ohrvik J, Hedin U, Paulsson-Berne G, Hamsten A, Eriksson P and Hansson GK: Genetic variants of TNFSF4 and risk for carotid artery disease and stroke. J Mol Med 87: 337-346, 2009.